Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell

Deficiency of Anterior Cruciate Ligament Clinical Trial

Official title:
A Randomized, Single Center, Investigator Initiated Clinical Trial to Evaluate Enhancement of Healing Between Bone Tunnel and Graft in Anterior Cruciate Ligament (ACL) Injury Using Human Umbilical Cord Blood Derived Mesenchymal Stem Cell

Status Completed

Clinical Trial Summary

Purpose:Development of novel strategy for treatment of anterior cruciate ligament (ACL) injury using stem cell.

Clinical Trial Description

1. Purpose: Development of novel strategy for treatment of anterior cruciate ligament (ACL) injury using stem cell.

2. Subject: Anterior cruciate ligament (ACL) injury 30 patients

- ACL reconstruction: 10

- ACL reconstruction + Human cord blood derived mesenchymal stem cells and hyaluronic acid (Cartistem (TM)): 10

- ACL reconstruction + hyaluronic acid: 10

3. Hypothesis: Human Cord blood derived mesenchymal stem cells can enhance healing between bone tunnel and graft in ACL reconstruction. ;

Study Design

Related Conditions & MeSH terms

Deficiency of Anterior Cruciate Ligament

Clinical Trial Details

NCT number	NCT02755376
Study type	Interventional
Source	Samsung Medical Center
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2014
Completion date	December 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT00529958` - Comparison of Three Methods for Anterior Cruciate Ligament Reconstruction	N/A
Completed	`NCT02382341` - BIOSURE™ HEALICOIL™ PK Bone In-growth Study
Completed	`NCT01607437` - Clinical Follow-up After ACL Reconstruction	N/A
Recruiting	`NCT02626975` - MRI Study of Ballooning and Ligamentisation Short Transplants ACL Hamstring According to Technical DT4